Phase 2 Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)
Year: 2021
Type: conference-abstract
Source: Blood
Authors: David S. Ziegler, Van Huynh, Michael J. Burke, Lia Gore, Franco Locatelli, Maureen M. O'Brien, Christopher Kim, Mihaela Obreja, Christopher L. Morris, André Baruchel
Institutions: Sydney Children's Hospital, Children's Hospital of Orange County, Children's Hospital of Wisconsin, Medical College of Wisconsin, Children's Hospital Colorado, Bambino Gesù Children's Hospital, Cincinnati Children's Hospital Medical Center, Amgen (United States), Université Paris Cité, Hôpital Robert-Debré
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4200266540